Tropical Data: Approach and Methodology as Applied to Trachoma Prevalence Surveys
- PMID: 38085791
- PMCID: PMC10751062
- DOI: 10.1080/09286586.2023.2249546
Tropical Data: Approach and Methodology as Applied to Trachoma Prevalence Surveys
Abstract
Purpose: Population-based prevalence surveys are essential for decision-making on interventions to achieve trachoma elimination as a public health problem. This paper outlines the methodologies of Tropical Data, which supports work to undertake those surveys.
Methods: Tropical Data is a consortium of partners that supports health ministries worldwide to conduct globally standardised prevalence surveys that conform to World Health Organization recommendations. Founding principles are health ministry ownership, partnership and collaboration, and quality assurance and quality control at every step of the survey process. Support covers survey planning, survey design, training, electronic data collection and fieldwork, and data management, analysis and dissemination. Methods are adapted to meet local context and needs. Customisations, operational research and integration of other diseases into routine trachoma surveys have also been supported.
Results: Between 29th February 2016 and 24th April 2023, 3373 trachoma surveys across 50 countries have been supported, resulting in 10,818,502 people being examined for trachoma.
Conclusion: This health ministry-led, standardised approach, with support from the start to the end of the survey process, has helped all trachoma elimination stakeholders to know where interventions are needed, where interventions can be stopped, and when elimination as a public health problem has been achieved. Flexibility to meet specific country contexts, adaptation to changes in global guidance and adjustments in response to user feedback have facilitated innovation in evidence-based methodologies, and supported health ministries to strive for global disease control targets.
Keywords: Chlamydia trachomatis; Tropical Data; prevalence; survey; trachoma.
Conflict of interest statement
Conflict of interests
AB, SB, PE, KR and PJH are (and CB and RW were) employed by the International Trachoma Initiative at The Task Force for Global Health, which receives an operating budget and research funds from Pfizer Inc., the manufacturers of Zithromax® (azithromycin). EMHE receives salary support from the International Trachoma Initiative. No other authors declare any conflict of interest.
Figures
References
-
- WHO. Ending the neglect to attain the Sustainable Development Goals – A road map for neglected tropical diseases 2021–2030. . Published online 2020.
-
- Taylor HR, Johnson SL, Prendergast RA, Schachter J, Dawson CR, Silverstein AM. An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci. 1982;23(4):507–515. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous